ArcticZymes Technologies Changes to the Board of Directors

Tromsø, Norway, May 13^th, 2024 – ArcticZymes Technologies (OSE: AZT) announces Nominations for new Board members and the resignation of the Chairman and a Board member.

ArcticZymes today announces changes to its governance structure. The Election committee has proposed changes to the Board to guide and strengthen the strategic and commercial development of the company.

Nomination of New Board Members

ArcticZymes is pleased to introduce three distinguished individuals nominated to join its Board of directors. These nominees bring expertise and experience in the biomanufacturing and financial sectors, enriching ArcticZymes' strategic direction, commercialization efforts, and governance practices:

• Mrs. Sharon Brownlow: With a background in Biotech and extensive experience in the cell and gene therapy industry, Mrs. Brownlow is renowned for blending her scientific roots with entrepreneurial drive. Her proven track record includes senior commercial roles in Catapult and Cobra Biologics, where she effectively drove strategic business momentum and long-term revenue growth.

• Mr. Petter Dragesund: Former Senior Partner at Pareto Securities, Mr. Dragesund boasts nearly three decades of experience in investment banking. Serving in various capacities at Pareto from 1992 to 2021, including Head of the Corporate Finance department from 2001 to 2014, he brings invaluable financial acumen to the Board. Since 2021, Mr. Dragesund has been an independent investor, further broadening his insights into market dynamics.

• A third Board member, currently a Life Science Executive, will be nominated shortly. With a remarkable track record in scaling public life science companies and devising successful growth strategies, this individual possesses deep insights into the challenges and opportunities within drug development and commercialization broadly.

Resignation of Chairman and Board Member

Mrs. Marie Roskrow, Chairman of the Board, has resigned, effective immediately. During her six-year tenure, Mrs. Roskrow played a pivotal role in elevating ArcticZymes into a globally profitable player in the life science tools sector. Her leadership laid a robust foundation for long-term growth, for which the Election committee extends its sincere appreciation.

Board member Mrs. Jane Theaker has also resigned, citing personal reasons. The committee acknowledges Mrs. Theaker's valuable contributions and thanks her for her service.

New date of the Annual General Meeting (AGM) is June 26^th, 2024

For practical reasons ArcticZymes has decided to move its Annual General Meeting (AGM), originally scheduled for June 5^th, to June 26^th, 2024. The financial calendar will be updated as well.

For more information, please contact:

ArcticZymes Technologies ASA
CEO,  MIchael B. Akoh                      
CFO, Børge Sørvoll                            
ir@arcticzymes.com

‍